Early treatment with sofosbuvir to prevent hcv recurrence after liver transplantation: a case report

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: WANG, Tair Shin (China Taiwan)
  • Co-author(s): Tair Shin Wang
    Ting Yu Wei
    Tzu Hui Yeh
    Shu Hui Sun
  • Abstract:

    Background

    Recurrent hepatitis C virus (HCV) infection is the cause of graft failure for liver transplantation. Eradication of HCV infection prior to transplantation would be the ideal approach. However, treatment of patients with decompensated cirrhosis warrant careful regimen selection and close monitoring. Early treatment post-transplantation..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login